Corrigendum to ‘Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)’ [European Urology Oncology 3 (2021) 256–263] - Michele Marchioni, Maximilian Kriegmair, Mathias Heck, Thomas Amiel, Francesco Porpiglia, Enrico Checcucci, Riccardo Campi, Andrea Minervini, Andrea Mari, Siska Van Bruwaene, Estefania Linares, Vital Hevia, Mireia Musquera, Mauricio D’Anna, Ithaar Derweesh - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

Published in

Elsevier, European Urology Oncology, 3(4), p. 517, 2021

DOI: 10.1016/j.euo.2021.04.007

Links

Tools

Export citation

Search in Google Scholar

Corrigendum to ‘Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)’ [European Urology Oncology 3 (2021) 256–263]

Journal article published in 2021 by Michele Marchioni, Maximilian Kriegmair, Mathias Heck, Thomas Amiel, Francesco Porpiglia, Enrico Checcucci, Riccardo Campi, Andrea Minervini, Andrea Mari, Siska Van Bruwaene, Estefania Linares, Vital Hevia, Mireia Musquera, Mauricio D’Anna, Ithaar Derweesh and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO